Related Experiment Video
Updated: Jun 5, 2026

An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor Tissues
Published on: April 5, 2018
Epigenetic aberrations during oncogenesis
Maria Hatziapostolou1, Dimitrios Iliopoulos
1Department of Cancer Immunology & AIDS, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Abstract:
The aberrant epigenetic landscape of a cancer cell is characterized by global genomic hypomethylation, CpG island promoter hypermethylation of tumor suppressor genes, and changes in histone modification patterns, as well as altered expression profiles of chromatin-modifying enzymes. Recent advances in the field of epigenetics have revealed that microRNAs' expression is also under epigenetic regulation and that certain microRNAs control elements of the epigenetic machinery. The reversibility of epigenetic marks catalyzed the development of epigenetic-altering drugs. However, a better understanding of the intertwined relationship between genetics, epigenetics and microRNAs is necessary in order to resolve how gene expression aberrations that contribute to tumorigenesis can be therapeutically corrected.
Insights
Cancer cells exhibit altered epigenetic patterns, including DNA methylation and histone modifications. Understanding the interplay between genetics, epigenetics, and microRNAs is crucial for developing targeted cancer therapies.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer cells display a distinct epigenetic landscape, including global hypomethylation and tumor suppressor gene hypermethylation.
- MicroRNA expression is epigenetically controlled, and microRNAs can influence epigenetic regulators.
- The dynamic nature of epigenetic modifications enables the development of epigenetic-altering drugs.
Purpose of the Study:
- To explore the intricate relationship between genetics, epigenetics, and microRNAs in cancer.
- To identify therapeutic targets for correcting gene expression aberrations in tumorigenesis.
Main Methods:
- Review of current literature on cancer epigenetics and microRNA regulation.
- Analysis of epigenetic mechanisms in tumor suppressor gene regulation.
- Investigation of microRNA's role in modulating the epigenetic machinery.
Main Results:
- Aberrant epigenetic modifications are hallmarks of cancer cells.
- MicroRNAs are integral components of the epigenetic regulatory network in cancer.
- Epigenetic reversibility offers a window for therapeutic intervention.
Conclusions:
- A comprehensive understanding of the genetics-epigenetics-microRNA axis is essential for effective cancer treatment.
- Targeting the epigenetic machinery offers a promising strategy for cancer therapy.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Abnormal Proliferation
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
